Human Vaccines & Immunotherapeutics

HPV vaccine coverage among adults aged 27-45: Implications for oropharyngeal cancer prevention

Cross-sectional study of 8,745 peoplePopulations

Declared ties to: Pfizer, Merck & Co., Moderna and 1 more

The paper